Cellular studies have previously demonstrated the requirement of autophagy for the clearance of SOD1 [78], and more recently for TDP-43, another aggregate-prone protein, mutations in which cause ALS [79,80] suggesting that there may be therapeutic potential for the upregulation of autophagy in ALS. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.